Current Status of Poly(ADP-ribose) Polymerase Inhibitors as Novel Therapeutic Agents for Triple-Negative Breast Cancer

Figure 1

A Venn diagram representing the connection of TNBC, basal-like breast cancer, and BRCA-mutated breast cancer.